Pretargeted Radioimmunotherapy (RIT) with a Novel Anti-TAG-72 Fusion Protein-Reference-Cited by-同舟云学术

Pretargeted Radioimmunotherapy (RIT) with a Novel Anti-TAG-72 Fusion Protein

Published:2005-08 Issue:4 Volume:20 Page:379-390
ISSN:1084-9785
Container-title:Cancer Biotherapy and Radiopharmaceuticals
language:en
Short-container-title:Cancer Biotherapy and Radiopharmaceuticals

Author:

Forero-Torres Andres¹,Shen Sui²,Breitz Hazel³,Sims Robert B.³,Axworthy Don B.³,Khazaeli M.B.²,Chen Kuang-Ho¹,Percent Ivor¹,Besh Stephen¹,LoBuglio Albert F.¹

Affiliation:

1. Departments of Medicine, Division of Hematology/Oncology University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL.

2. Radiation Oncology, University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL.

3. Clinical Development, NeoRx Corporation, Seattle, WA.

Publisher

Mary Ann Liebert Inc

Subject

Cancer Research,Pharmacology,Radiology Nuclear Medicine and imaging,Oncology,General Medicine,Cancer Research,Pharmacology,Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/cbr.2005.20.379

Reference31 articles.

1. Monoclonal Antibody Therapy for Cancer

2. Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.

3. CAMPATH-1H monoclonal antibody in therapy for previously treated low-grade non-Hodgkin's lymphomas: a phase II multicenter study. European Study Group of CAMPATH-1H Treatment in Low-Grade Non-Hodgkin's Lymphoma.

4. Multinational Study of the Efficacy and Safety of Humanized Anti-HER2 Monoclonal Antibody in Women Who Have HER2-Overexpressing Metastatic Breast Cancer That Has Progressed After Chemotherapy for Metastatic Disease

5. Phase I Safety and Pharmacokinetic Study of Recombinant Human Anti-Vascular Endothelial Growth Factor in Patients With Advanced Cancer

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clearing and Masking Agents in Pretargeting Strategies;Pharmaceuticals;2023-03-27

2. Cucurbituril–Ferrocene: Host–Guest Based Pretargeted Positron Emission Tomography in a Xenograft Model;Bioconjugate Chemistry;2021-06-22

3. Combination Radioimmunotherapy Strategies for Solid Tumors;International Journal of Molecular Sciences;2019-11-08

4. Therapeutic Applications of Pretargeting;Pharmaceutics;2019-09-01

5. Chemically triggered drug release from an antibody-drug conjugate leads to potent antitumour activity in mice;Nature Communications;2018-05-04